People diagnosed with chronic lymphocytic leukaemia (CLL) will be tested for two gene mutations in a new pilot program to determine whether they will benefit from standard chemotherapy or novel therapies. Under the program at Peter MacCallum Cancer Centre’s molecular haematology laboratory in Melbourne, 240 patients aged 70 or under will be tested for mutations ...
Pilot program will use gene testing to guide CLL treatment
By Tessa Hoffman
30 May 2018